Based at Riley Children’s Hospital at IU Health, the NeuroNICU program provides expert care, targeted surveillance, evidence-based treatment options and support for newborns with serious neurologic problems, including seizures, intracranial hemorrhage, hypoxic-ischemic encephalopathy, malformations, and hydrocephalus. Thirty to forty percent of all NICU admissions are followed and treated through the program. A collaboration between the Level IV NICU and the highly ranked IU School of Medicine Pediatric Neurology department, the NeuroNICU program is the only neonatal neurocritical care program within the state of Indiana.
Riley Hospital is one of few hospitals worldwide offering neurotelemetry for neonates. Dedicated technicians, epileptologists, and pediatric neurologists follow the video EEG in real time 24/7.
With more than 15 years of experience, faculty care teams provide whole body hypothermia for babies with hypoxic-ischemic encephalopathy, also known as HIE or birth asphyxia. All infants are monitored with neurotelemetry during hypothermia treatment. Active cooling is also available during transport.
Increased use of modern MRI technology allows a reduction in infants’ exposure to radiation. IU School of Medicine pediatric neuroradiologists are interpret all neonatal images. In conjunction with physicists, imaging technology can be tailored to the need of neonates.
Faculty pediatric neurosurgeons of IU School of Medicine provide comprehensive, expert care with innovative surgical techniques.
Comprehensive multidisciplinary prenatal consultation is provided to families with high-risk pregnancies and neurological/neurosurgical diagnosis. The multidisciplinary team is tailored to the patients need and may include IU School of Medicine specialists in Neonatology, Neurology, Neurosurgery, Palliative Care, Genetic counseling, and Maternal-Fetal Medicine.
In partnership with developmental pediatricians and the Newborn Follow-up Program, the NeuroNICU follow-up service ensures that each infant continues to make strides following treatment in the NeuroNICU at Riley at IU Health.